Access cutting-edge hematological malignancy treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbia location
Preparing your pre-screening questions…
Access hematological malignancy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hematological malignancy treatment provided free
Check if you qualify for this hematological malignancy clinical trial in Columbia, MO
No-Cost Study Care
Local to Columbia
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Acute myeloid leukemia (AML) accounts for more than 40% of leukemia mortality in the United States. Each year around ten thousand people die from the disease, most within a few years of diagnosis. Despite advances in our understanding of the disease, few improvements in the therapy of AML have been made. Collecting specimens from the blood and bone marrow will increase understanding of the effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors on human AML-SCP to develop individualized therapies. We also found DPP4 is highly expressed in other hematological malignancies in our mouse model, thus we would like to use human samples to investigate the role of DPP4 in hematological malignancy development and the mechanism underlying, especially to deeply understand the role of DDP4 in leukemia.
Sponsor: University of Missouri-Columbia
Yes, this clinical trial (NCT04841447) has an active research site in Columbia, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hematological malignancy treatment options in Columbia, MO, this clinical trial (NCT04841447) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematological malignancy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hematological malignancy clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Columbia — not just this study.
Browse Interstitial Cystitis Trials in Columbia →